Literature DB >> 25628319

Intense pruritus in Epstein-Barr virus (EBV) hepatitis treated with naloxone drip.

Satyanisth Agrawal1, Ryan O'Connor1, Elie Aoun1, Michael Babich1.   

Abstract

Pruritus is a manifestation of chronic liver disease. Epstein-Barr virus (EBV) infection often presents as infectious mononucleosis and mild hepatitis. Severe pruritus in the setting of infectious mononucleosis and persistent marked hyperbilirubinaemia is exceedingly uncommon. To the best of our knowledge, we present the first case of a patient with EBV hepatitis and severe pruritus that was successfully treated with an ultra-low dose of intravenous naltraxone. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25628319      PMCID： PMC4322269          DOI： 10.1136/bcr-2014-207037

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

Review 1.  Viral diseases involving the liver.

Authors:  B N Tandon; S K Acharya
Journal:  Baillieres Clin Gastroenterol       Date:  1987-04

2.  Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.

Authors:  E A Jones; L R Dekker
Journal:  Gastroenterology       Date:  2000-02       Impact factor: 22.682

3.  Location of regions of the opioid receptor involved in selective agonist binding.

Authors:  K Fukuda; S Kato; K Mori
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

4.  Marked hyperbilirubinemia in infectious mononucleosis. Analysis of laboratory data in seven patients.

Authors:  S A Fuhrman; R Gill; C A Horwitz; W Henle; G Henle; G Kravitz; J Baldwin; J Tombers
Journal:  Arch Intern Med       Date:  1987-05

Review 5.  The clinical expression of primary biliary cirrhosis.

Authors:  J Heathcote
Journal:  Semin Liver Dis       Date:  1997-02       Impact factor: 6.115

6.  Haemolytic anaemia complicating Epstein-Barr virus infection.

Authors:  F Whitelaw; M G Brook; N Kennedy; W R Weir
Journal:  Br J Clin Pract       Date:  1995 Jul-Aug

7.  Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.

Authors:  N V Bergasa; D W Alling; T L Talbot; M G Swain; C Yurdaydin; M L Turner; J M Schmitt; E C Walker; E A Jones
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

8.  The mu opioid receptor: from molecular cloning to functional studies.

Authors:  L Yu
Journal:  Addict Biol       Date:  1996       Impact factor: 4.280

9.  A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.

Authors:  N V Bergasa; T L Talbot; D W Alling; J M Schmitt; E C Walker; B L Baker; J C Korenman; Y Park; J H Hoofnagle; E A Jones
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

10.  Opioid peptides and primary biliary cirrhosis.

Authors:  J R Thornton; M S Losowsky
Journal:  BMJ       Date:  1988-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.